Friday, January 22, 2021
Pitt-Led NIH Trial Platform Shows Blood Thinners Decrease Need for Life Support in COVID-19 Patients
Early results of the trial, which is part of a three-trial platform consortium spanning more than 300 hospitals worldwide, found that full doses of heparin, a blood thinner, were not only safe but also reduced the need for vital organ support, such as ventilation.
Tuesday, December 15, 2020
Optimism is hardwired in most humans, says public health professor Steve Albert. If you don’t feel like you’re one of them right now, here are three perspectives on why, despite all that 2020 brought us, things are looking brighter.
Friday, October 23, 2020
Thursday, September 3, 2020
A study led by pathology’s Samira Kiani and published today in Nature Cell Biology showed that a new approach to CRISPR briefly suppressed genes to control the immune response in mice, making gene therapy delivery more effective.
Monday, May 11, 2020
A new School of Medicine discovery in mice showed the innate immune system has "memory" that, when inhibited, lengthens organ transplant survival.
Wednesday, April 22, 2020
Monday, March 23, 2020
The Coalition for Epidemic Preparedness Innovations is committing nearly $5 million to a consortium that includes the University of Pittsburgh’s Center for Vaccine Research to develop a vaccine for the novel coronavirus.
Wednesday, November 20, 2019
Friday, June 21, 2019
A text messaging program called MILK developed in the School of Nursing educates and encourages new parents who breastfeed. The lead researcher, Jill Demirci (NURS ’05, ’10G, ’12G), focuses on developing a variety of clinical and community-based interventions to help mothers meet their breastfeeding goals.
Wednesday, January 30, 2019
A recent study led by Pitt’s Inmaculada Hernandez found that new drugs entering the market drive up prices, but drug companies are also hiking prices on older drugs.